These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14691264)

  • 41. Repeated maternal separation: differences in cocaine-induced behavioral sensitization in adult male and female mice.
    Kikusui T; Faccidomo S; Miczek KA
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):202-10. PubMed ID: 15322726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
    Boulay D; Duterte-Boucher D; Leroux-Nicollet I; Naudon L; Costentin J
    J Pharmacol Exp Ther; 1996 Jul; 278(1):330-7. PubMed ID: 8764367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Self-administration of two long-acting monoamine transport blockers in rhesus monkeys.
    Lile JA; Morgan D; Freedland CS; Sinnott RS; Davies HM; Nader MA
    Psychopharmacology (Berl); 2000 Nov; 152(4):414-21. PubMed ID: 11140334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cocaine withdrawal reduces dopamine transporter binding in the shell of the nucleus accumbens.
    Pilotte NS; Sharpe LG; Rountree SD; Kuhar MJ
    Synapse; 1996 Jan; 22(1):87-92. PubMed ID: 8822482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Localization of the delta-opioid receptor and dopamine transporter in the nucleus accumbens shell: implications for opiate and psychostimulant cross-sensitization.
    Svingos AL; Clarke CL; Pickel VM
    Synapse; 1999 Oct; 34(1):1-10. PubMed ID: 10459166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abolished cocaine reward in mice with a cocaine-insensitive dopamine transporter.
    Chen R; Tilley MR; Wei H; Zhou F; Zhou FM; Ching S; Quan N; Stephens RL; Hill ER; Nottoli T; Han DD; Gu HH
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9333-8. PubMed ID: 16754872
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine.
    Povlock SL; Schenk JO
    J Neurochem; 1997 Sep; 69(3):1093-105. PubMed ID: 9282932
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dopamine hypothesis of the reinforcing properties of cocaine.
    Kuhar MJ; Ritz MC; Boja JW
    Trends Neurosci; 1991 Jul; 14(7):299-302. PubMed ID: 1719677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DAT isn't all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling.
    Northcutt AL; Hutchinson MR; Wang X; Baratta MV; Hiranita T; Cochran TA; Pomrenze MB; Galer EL; Kopajtic TA; Li CM; Amat J; Larson G; Cooper DC; Huang Y; O'Neill CE; Yin H; Zahniser NR; Katz JL; Rice KC; Maier SF; Bachtell RK; Watkins LR
    Mol Psychiatry; 2015 Dec; 20(12):1525-37. PubMed ID: 25644383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased ethanol preference and consumption in dopamine transporter female knock-out mice.
    Savelieva KV; Caudle WM; Findlay GS; Caron MG; Miller GW
    Alcohol Clin Exp Res; 2002 Jun; 26(6):758-64. PubMed ID: 12068242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The top 20 dopamine transporter mutants: structure-function relationships and cocaine actions.
    Uhl GR; Lin Z
    Eur J Pharmacol; 2003 Oct; 479(1-3):71-82. PubMed ID: 14612139
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Addiction-related effects of DOV 216,303 and cocaine: A comparative study in the mouse.
    Sørensen G; Husum H; Brennum LT; Bundgaard C; Montezinho LC; Mørk A; Wörtwein G; Woldbye DP
    Basic Clin Pharmacol Toxicol; 2014 Jun; 114(6):451-9. PubMed ID: 24314270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cocaine-conditioned locomotion in dopamine transporter, norepinephrine transporter and 5-HT transporter knockout mice.
    Hall FS; Li XF; Randall-Thompson J; Sora I; Murphy DL; Lesch KP; Caron M; Uhl GR
    Neuroscience; 2009 Sep; 162(4):870-80. PubMed ID: 19482066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Dopamine control of neuroendocrine functions. New findings based on the study of transgenic animals].
    Jaber M
    Ann Endocrinol (Paris); 1997; 58(6):427-35. PubMed ID: 9686001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and synthesis of an irreversible dopamine-sparing cocaine antagonist.
    Meltzer PC; Liu S; Blanchette H; Blundell P; Madras BK
    Bioorg Med Chem; 2002 Nov; 10(11):3583-91. PubMed ID: 12213473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of the dopamine transporter in cocaine abuse.
    Izenwasser S
    Neurotox Res; 2004; 6(5):379-83. PubMed ID: 15545021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse.
    Clauss NJ; Mayer FP; Owens WA; Vitela M; Clarke KM; Bowman MA; Horton RE; Gründemann D; Schmid D; Holy M; Gould GG; Koek W; Sitte HH; Daws LC
    Mol Psychiatry; 2023 Jul; 28(7):2934-2945. PubMed ID: 37308680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypocretin receptor 1 involvement in cocaine-associated behavior: Therapeutic potential and novel mechanistic insights.
    Brodnik ZD; Alonso IP; Xu W; Zhang Y; Kortagere S; España RA
    Brain Res; 2020 Mar; 1731():145894. PubMed ID: 30071195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The slow and long-lasting blockade of dopamine transporters in human brain induced by the new antidepressant drug radafaxine predict poor reinforcing effects.
    Volkow ND; Wang GJ; Fowler JS; Learned-Coughlin S; Yang J; Logan J; Schlyer D; Gatley JS; Wong C; Zhu W; Pappas N; Schueller M; Jayne M; Carter P; Warner D; Ding YS; Shea C; Xu Y
    Biol Psychiatry; 2005 Mar; 57(6):640-6. PubMed ID: 15780851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants.
    Drago J; Padungchaichot P; Accili D; Fuchs S
    Dev Neurosci; 1998; 20(2-3):188-203. PubMed ID: 9691193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.